ID

21236

Descripción

Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00313248

Link

https://clinicaltrials.gov/show/NCT00313248

Palabras clave

Versiones (1)
  1. 16/4/17 16/4/17 -
Subido en

16 de abril de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Neoplasm NCT00313248

Inglés

Eligibility Breast Neoplasm NCT00313248

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
metastatic breast cancer (meaning the cancer has spread beyond its original location)
Descripción

metastatic breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0278488
at least one measurable lesion by ct or mri
Descripción

breast cancer measurable lesion

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0006142
UMLS CUI [1,2]
C1513041
UMLS CUI [1,3]
C0011923
progression of disease following previous therapy for breast cancer
Descripción

progression after breast cancer therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0006142
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0242656
have received previous treatment with anthracyclines (e.g. doxorubicin[adriamycin or doxil] or epirubicin [ellence]), taxanes (paclitaxel [taxol or abraxane] or docetaxel [taxotere]) for your breast cancer
Descripción

anthracyclines or taxanes therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0282564
UMLS CUI [2]
C0796419
not be pregnant
Descripción

pregnancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
additional criteria to be determined at screening visit.
Descripción

additional inclusion criteria

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C1524062
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
more than 3 previous chemotherapy regimens
Descripción

previous chemotherapy regimens

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0205156
more than one treatment with non cytotoxic agents for breast cancer therapy (e.g. herceptin [trastuzumab] or avastin [bevacizumab)
Descripción

breast cancer therapy with non cytotoxic agents

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0006142
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C2827065
prior treatment with epothilones (e.g. ixabepilone)
Descripción

treatment with epothilones

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1136012
symptomatic brain metastases
Descripción

symptomatic brain metastases

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0231220
additional criteria to be determined at screening visit
Descripción

additional exclusion criteria

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1524062
Volver a la parte superior de la página

Similar models

Eligibility Breast Neoplasm NCT00313248

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
metastatic breast cancer
Item
metastatic breast cancer (meaning the cancer has spread beyond its original location)
boolean
C0278488 (UMLS CUI [1])
breast cancer measurable lesion
Item
at least one measurable lesion by ct or mri
boolean
C0006142 (UMLS CUI [1,1])
C1513041 (UMLS CUI [1,2])
C0011923 (UMLS CUI [1,3])
progression after breast cancer therapy
Item
progression of disease following previous therapy for breast cancer
boolean
C0006142 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0242656 (UMLS CUI [1,3])
anthracyclines or taxanes therapy
Item
have received previous treatment with anthracyclines (e.g. doxorubicin[adriamycin or doxil] or epirubicin [ellence]), taxanes (paclitaxel [taxol or abraxane] or docetaxel [taxotere]) for your breast cancer
boolean
C0282564 (UMLS CUI [1])
C0796419 (UMLS CUI [2])
pregnancy
Item
not be pregnant
boolean
C0032961 (UMLS CUI [1])
additional inclusion criteria
Item
additional criteria to be determined at screening visit.
boolean
C1512693 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
previous chemotherapy regimens
Item
more than 3 previous chemotherapy regimens
boolean
C0392920 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
breast cancer therapy with non cytotoxic agents
Item
more than one treatment with non cytotoxic agents for breast cancer therapy (e.g. herceptin [trastuzumab] or avastin [bevacizumab)
boolean
C0006142 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C2827065 (UMLS CUI [1,3])
treatment with epothilones
Item
prior treatment with epothilones (e.g. ixabepilone)
boolean
C1136012 (UMLS CUI [1])
symptomatic brain metastases
Item
symptomatic brain metastases
boolean
C0220650 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
additional exclusion criteria
Item
additional criteria to be determined at screening visit
boolean
C0680251 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial